Skip to content

Clinical trials

Phase 3 Renal Insufficiency, Chronic trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Country / region: Japan Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20101
20122
20131
20141
20151
20162
20175
20183
20192
20201
20213
20233
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting6
Active, not recruiting5
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc7
AstraZeneca6
Bayer6
Novartis Pharmaceuticals4
GlaxoSmithKline3
Alexion Pharmaceuticals, Inc.2
Boehringer Ingelheim2
Biogen1
Eli Lilly and Company1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic36
Anemia10
Glomerulonephritis, IGA5
Hyperphosphatemia5
Kidney Diseases5
Renal Insufficiency5
Glomerulonephritis4
Urologic Diseases3
Diabetes Mellitus, Type 22
Diabetic Nephropathies2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.